同大類學(xué)科其它級(jí)別期刊:
中科院 1區(qū) 期刊 JCR Q1 期刊 中科院 2區(qū) 期刊 JCR Q2 期刊 中科院 3區(qū) 期刊 JCR Q3 期刊 中科院 4區(qū) 期刊 JCR Q4 期刊國(guó)際簡(jiǎn)稱:ARP RHEUMATOL 參考譯名:Arp 風(fēng)濕病學(xué)
主要研究方向:RHEUMATOLOGY 非預(yù)警期刊 審稿周期:
《Arp 風(fēng)濕病學(xué)》(Arp Rheumatology)是一本由Sociedade Portuguesa de Reumatologia出版的以RHEUMATOLOGY為研究特色的國(guó)際期刊,發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章,及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn),旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊,近三年沒有被列入預(yù)警名單。
《Arthritis & Rheumatology》 is a long-standing academic journal known for its scientific rigor and contributions to the field of rheumatology since its inception in 1973. As a double-blind peer-reviewed journal, it ensures that published research papers meet high standards of scientific and academic rigor. Meanwhile, as an open access journal, it allows researchers, doctors, and scholars worldwide to access its content for free, thereby promoting knowledge sharing and dissemination.
This journal focuses on various aspects of rheumatism and musculoskeletal diseases, including but not limited to the pathogenesis, diagnostic methods, treatment strategies, and preventive measures of the disease. It provides a platform for researchers to share their latest discoveries and innovative achievements in these fields. Whether it is basic scientific research or clinical research, high-quality research related to rheumatism and musculoskeletal health can be submitted to Arthritis&Rheumatology.
The readership of the magazine includes rheumatologists, immunologists, internal medicine doctors, orthopedic doctors, researchers, as well as students and professionals interested in these fields. The publication of journals not only helps to promote scientific progress in the field of rheumatology, but also provides guidance and reference for clinical practice, helping doctors provide better treatment plans for patients.
CiteScore | SJR | SNIP | CiteScore 指數(shù) | ||||||||
1.2 | 0.224 | 0.3 |
|
名詞解釋:CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù),是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年(含計(jì)算年度)的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如,2022年的 CiteScore 計(jì)算方法為:2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量 注:文獻(xiàn)類型包括:文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。
Top期刊 | 綜述期刊 | 大類學(xué)科 | 小類學(xué)科 | ||
否 | 否 | 醫(yī)學(xué) | 4區(qū) | RHEUMATOLOGY 風(fēng)濕病學(xué) | 4區(qū) |
按JIF指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:RHEUMATOLOGY | SCIE | Q3 | 40 / 57 |
30.7% |
按JCI指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:RHEUMATOLOGY | SCIE | Q4 | 43 / 57 |
25.44% |
Frontiers In Public Health
中科院 3區(qū) JCR Q2
Frontiers In Pharmacology
中科院 2區(qū) JCR Q1
Biomedicine & Pharmacotherapy
中科院 2區(qū) JCR Q1
Bmc Psychiatry
中科院 2區(qū) JCR Q2
Discover Oncology
中科院 4區(qū) JCR Q2
Bmc Neurology
中科院 3區(qū) JCR Q3
Medcomm
中科院 3區(qū) JCR Q1
Journal Of Materials Chemistry B
中科院 3區(qū) JCR Q1